Last reviewed · How we verify
Nosocomial Pneumonia due to Haemophilus Influenzae
Approved treatments
- Ciprofloxacine · Poitiers University Hospital
- Noroxin
- Floxin
- Cipro · Bayer AG
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nosocomial Pneumonia due to Haemophilus Influenzae patent landscape — cliff calendar, originator estates, attackable patents
- Nosocomial Pneumonia due to Haemophilus Influenzae treatment landscape brief
- Nosocomial Pneumonia due to Haemophilus Influenzae treatment updates RSS
Frequently asked questions about Nosocomial Pneumonia due to Haemophilus Influenzae
What drugs treat Nosocomial Pneumonia due to Haemophilus Influenzae?
Tracked treatments include Ciprofloxacine, Noroxin, Floxin, Cipro, Levaquin, Ofloxacine.
What is the treatment for Nosocomial Pneumonia due to Haemophilus Influenzae?
Standard treatment for Nosocomial Pneumonia due to Haemophilus Influenzae includes Ciprofloxacine, Noroxin, Floxin, Cipro, Levaquin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nosocomial Pneumonia due to Haemophilus Influenzae patent cliff · Nosocomial Pneumonia due to Haemophilus Influenzae CI report
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Cipro · Bayer AG
- Treatment: Levaquin · Generic (originally Daiichi Sankyo/J&J)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing